NumerixS Investment Technologies Inc - TG THERAPEUTICS INC ownership

TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 105 filers reported holding TG THERAPEUTICS INC in Q2 2017. The put-call ratio across all filers is 1.01 and the average weighting 0.1%.

Quarter-by-quarter ownership
NumerixS Investment Technologies Inc ownership history of TG THERAPEUTICS INC
ValueSharesWeighting
Q3 2019$24,000
-52.0%
4,300
-65.9%
0.01%
-62.5%
Q4 2018$50,000
-60.0%
12,600
+32.6%
0.02%
-42.9%
Q2 2018$125,000
-7.4%
9,500
-1.0%
0.03%
-15.2%
Q1 2018$135,000
+419.2%
9,600
+200.0%
0.03%
+450.0%
Q4 2017$26,000
+225.0%
3,200
+300.0%
0.01%
+500.0%
Q2 2017$8,0008000.00%
Other shareholders
TG THERAPEUTICS INC shareholders Q2 2017
NameSharesValueWeighting ↓
Avoro Capital Advisors LLC 5,229,619$74,261,0003.55%
RA Capital Management 2,472,344$35,107,0002.69%
SENZAR ASSET MANAGEMENT, LLC 475,918$6,758,0002.13%
BRIDGER MANAGEMENT, LLC 2,373,920$33,710,0002.04%
Opaleye Management Inc. 274,200$3,893,0001.11%
Virtus ETF Advisers LLC 89,920$1,277,0001.11%
Eversept Partners, LP 150,000$2,130,0000.99%
Ghost Tree Capital, LLC 300,000$4,260,0000.86%
PURA VIDA INVESTMENTS, LLC 50,000$710,0000.42%
HIGHLAND CAPITAL MANAGEMENT LP 464,391$6,595,0000.34%
View complete list of TG THERAPEUTICS INC shareholders